Part IV
van der Vos KE, Eliasson P, Proikas-Cezanne T, Vervoort SJ, van Boxtel R, Putker M, van Zutphen IJ, Mauthe M, Zellmer S, Pals C, Verhagen LP, Groot Koerkamp MJ, Braat AK, Dansen TB, Holstege FC, Gebhardt R, Burgering BM, Coffer PJ
PMID 20200426
In contrast, many studies on metabolic modulators, herbal formulations, or supplements have been constrained by small sample sizes, short durations, and reliance on surrogate endpoints such as NT-proBNP reduction or improvements in left ventricular ejection fraction
Statements Author contributions AS: Conceptualization, Visualization, Resources, Validation, Formal Analysis, Project administration, Methodology, Data curation, Writing review & editing, Funding acquisition, Writing original draft, Investigation, Supervision, Software
The longer the chain, the higher the likelihood of such errorsand the lower the overall yield